Daily brief
AstraZeneca has announced a major expansion of its operations in China, including a $15 billion investment through 2030. The pharmaceutical company also struck a $4.7 billion deal with China's CSPC Pharmaceuticals to collaborate on developing weight-loss drugs. The CEO stated that investing in the Chinese market is essential for innovation.
Chinese state-owned aluminum company Chinalco and Australian mining giant Rio Tinto have agreed to buy control of Brazilian aluminum maker CBA from conglomerate Votorantim (ongoing coverage).
UK Prime Minister Keir Starmer said the UK 'can't ignore China' after President Donald Trump criticized his trade push, as China lifted sanctions on several UK MPs and peers.
A Chinese automotive firm will set up its European headquarters in Britain, as UK firms express optimism about growing opportunities with China during the Prime Minister's visit.
The UK-China Business Council has restarted its activities after an eight-year hiatus.